Muscle Relaxant Soma Now Schedule IV Controlled Substance
The DEA published its final rule scheduling Soma (carisoprodal) as a controlled substance on December 12. The rule takes effect on January 12, 2012.
From the FDA Law Blog of the law firm Hyman, Phelps & McNamara:
DEA Federally Controls Carisoprodol as a Schedule IV Substance, Establishes Regulatory Timeline
By Larry K. Houck –
The Drug Enforcement Administration (“DEA”) published its long awaited final rule in the Federal Register today (76 Fed. Reg. 77,330 (Dec. 12, 2011)) placing carisoprodol into schedule IV of the federal Controlled Substances Act (“CSA”). Federal scheduling of carisoprodol follows control of the drug by eighteen states around the country. Effective January 12, 2012, DEA’s placement pertains to carisoprodol (widely distributed under the trade name of Soma®), and its salts, isomers and salts of isomers.
DEA’s placement of carisoprodol in schedule IV subjects manufacturers, distributors, dispensers such as pharmacies and physicians, importers, exporters, and anyone in possession of the drug to the applicable provisions of the CSA and its implementing regulations, including administrative, civil and criminal sanctions.